|
|
Article: Cytokinetics Raises $40M To Move Pipeline Products Along.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Staff Writer
Cytokinetics Inc. generated $40 million of working capital in closing its fifth round of financing, a preferred stock offering.
The privately held company said it would use the Series E funds to further its partnered clinical development program and advance additional programs into clinical work. South San Francisco-based Cytokinetics is focused on cytoskeletal drug discovery and development in the areas of oncology, cardiovascular disease and antifungal therapeutics.
"I think our success in this financing is a function of two key issues," Robert Blum, Cytokinetics' senior vice president of finance and corporate development and ...